Method of treating schizophrenia and other disorders
AssigneeAstraZeneca AB
InventorsPatricia Davis, Jeffrey Goldstein, Scott Grimm, Helen Winter, Raymond Suckow
Life of this patent
Estimating the term…
Loading patent…
AssigneeAstraZeneca AB
InventorsPatricia Davis, Jeffrey Goldstein, Scott Grimm, Helen Winter, Raymond Suckow
Estimating the term…
A method of treating at least one symptom or condition associated with but not limited to: 1) Schizophrenia and other Psychotic Disorders including but not limited to Psychotic Disorder, Schizophreniform Disorder, Schizoaffective Disorder, Delusional Disorder, Brief Psychotic Disorder, Shared Psychotic Disorder, and Psychotic Disorder Due to a General Medical Condition and 2) Dementia and other Cognitive Disorders comprising administering an effective amount of Formula I or its pharmaceutically acceptable salt. In another aspect of the invention a pharmaceutical composition is provided comprising an effective amount of Formula I or its pharmaceutically acceptable salt and at least one pharmaceutically acceptable carrier or diluent.
A method of treating at least one symptom or condition associated with a Disorder selected from Schizophrenia and other Psychotic Disorders including:
An oral pharmaceutical composition comprising the compound of Formula I:
The composition as recited claim 12 wherein the Disorder is psychosis.
Dependencies are inferred from the claim text.